Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 1801 - 1825 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▼
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AK02
  • Fucalpha1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260693 1603.918527 C76H137N3O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AR02
  • GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260749 1603.918527 C76H137N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AF02
  • GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • type II A antigen(d18:1/18:0)
44261013 1603.918527 C76H137N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CG02
  • ClcNAc-Lex-5(d18:1/18:0)
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261437 1603.918527 C76H137N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CU02
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • type II A antigen(d18:1/18:0)
44261541 1603.918527 C76H137N3O32
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BI02
  • Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261693 1603.918527 C76H137N3O32
Gangliosides LMSP0601AK05
  • GD3(d18:1/24:0)
  • NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262048 1555.933782 C76H137N3O29
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC07
  • Forssman antigen(d18:1/24:1(15Z))
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260186 1539.938867 C76H137N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD07
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • Para-Forssman x3b(d18:1/24:1(15Z))
44260194 1539.938867 C76H137N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BC07
  • GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260394 1539.938867 C76H137N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BD07
  • GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260402 1539.938867 C76H137N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AC07
  • GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260506 1539.938867 C76H137N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AE07
  • GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260522 1539.938867 C76H137N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AO07
  • GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260602 1539.938867 C76H137N3O28
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AJ07
  • GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260690 1539.938867 C76H137N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AK07
  • GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • nLc5Cer(d18:1/24:1(15Z))
44261058 1539.938867 C76H137N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BN07
  • GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • P antigen(d18:1/24:1(15Z))
44261290 1539.938867 C76H137N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CE07
  • GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261426 1539.938867 C76H137N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AD07
  • Forssman-like iGb4(d18:1/24:1(15Z))
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261866 1539.938867 C76H137N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AO07
  • GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261930 1539.938867 C76H137N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BG07
  • GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261682 1539.938867 C76H137N3O28
Glycosyldiacylglycerols LMGL05010071
  • 1-(9Z-octadecenoyl)-2-(9,10-methylene-octadecanoic acid)-3-O-beta-d-glucopyranosyl-(1->6)-alpha-d-galactopyranosyl-(6-(9Z-octadecenoyl))-(1->2)-alpha-d-glucosyl-sn-glycerol
  • 1-oleoyl-2-Dihydrosterculoyl-3-O-beta-d-glucopyranosyl-(1->6)-alpha-d-galactopyranosyl-(6-(9Z-octadecenoyl))-(1->2)-alpha-d-glucosyl-sn-glycerol
171118824 1384.957415 C76H136O21
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BB01
  • GalNAcalpha1-3GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260380 1632.908691 C76H136N4O33
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AL01
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261900 1632.908691 C76H136N4O33
Diacylglycerophosphoinositolglycans LMGP15010235
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:1(9Z)/18:1(9Z))
126457603 1686.836908 C76H135O38P

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024